Intelligence Platform
Patents
Browse 3,063 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 6797275
Method of immunizing humans against Salmonella typhi using a Vi-rEPA conjugate vaccine
expired patentUS 6797276
Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous i
expired patentUS 6794498
Method of eliminating inhibitory/instability regions of mRNA
expired patentUS 6794188
Retrovirus vectors derived from avian sarcoma leukosis viruses permitting transfer of gene
expired patentUS 6794174
Full-length infectious cDNA clones of tick borne flavivirus
expired patentUS 6793927
Construction of Pasteurella haemolytica vaccines
expired patentUS 6790449
Methods for producing self-replicating infectious RSV particles comprising recombinant RSV
expired patentUS 6790936
CAI resistance proteins and uses thereof
expired patentUS 6787333
Retrovirus isolated from humans
expired patentUS 6787145
Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic meth
expired patentUS 6780413
Immunotoxin (mAB-RICIN) for the treatment of focal movement disorders
expired patentUS 6780847
Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, v
expired patentUS 6780417
Transmission blocking immunogen from malaria
expired patentUS 6773880
Streptococcus pneumoniale 37-kDa surface adhesion A protein
expired patentUS 6770291
Liposome complexes for increased systemic delivery
expired patentUS 6770479
Anthrax vaccine
expired patentUS 6767546
Use of echinacea as a feed additive to enhance protection against coccidiosis
expired patentUS 6765104
Transition metal complexes of n, n',n″trialkyl-cis-1,3,5-triaminocyclohexane and rel
expired patentUS 6761911
Use of chlorate ion or preparations thereof for reduction of food borne pathogens
expired patentUS 6756038
Agonist and antagonist peptides of carcinoembryonic antigen (CEA)
expired patentUS 6756399
Use of lipoxygenase inhibitors and PPAR ligands as anti-cancer therapeutic and interventio
expired patentUS 6756201
Diagnostic methods and gene therapy using reagents derived from the human metastasis suppr
expired patentUS 6753317
Dmt-Tic di- and tri-peptide derivatives and related compositions and methods of use
expired patentUS 6749856
Mucosal cytotoxic T lymphocyte responses
expired